top stories

Eli Lil­ly’s Dan Skovron­sky on oral GLP-1, ‘slow­er ramp’ for Alzheimer’s and deals on ‘un­der­ap­pre­ci­at­ed’ as­sets

6 hours ago
People
R&D

Neu­ro start­up stock craters af­ter PhI­II study marred with ‘sig­nif­i­cant de­vi­a­tion’ from tri­al pro­to­col

2 hours ago
Startups
R&D

Gen­er­a­tion Bio to lay off 68 em­ploy­ees in a dif­fi­cult year for non-vi­ral gene ther­a­py biotechs

1 hour ago
People
Cell/Gene Tx

Health in­sur­ance gi­ants Cigna and Hu­mana re­port­ed­ly in talks to merge

8 minutes ago
Health Tech

Latest

In­tas Phar­ma­ceu­ti­cal­s' In­di­an fa­cil­i­ty hit with FDA warn­ing let­ter, placed on im­port alert

33 minutes ago
FDA+
Manufacturing

Ar­ri­vo bags $45M Se­ries B to fund ma­jor de­pres­sion late-stage test and PhII-ready pan­cre­ati­tis as­set

2 hours ago
Financing
R&D

Lil­ly to pay up to $660M in new deal with PRISM Bi­o­Lab; Boehringer part­ners with Phe­nom­ic AI

2 hours ago
News Briefing

Verve rais­es $148M via pub­lic stock of­fer­ing, pri­vate place­ment with Eli Lil­ly (cor­rect­ed)

6 hours ago
Financing

FDA to make de­ci­sion about Karuna's schiz­o­phre­nia drug by next Sep­tem­ber

6 hours ago
R&D
FDA+

Am­gen teams up with Ama­zon on AI plat­form to en­hance new Ohio man­u­fac­tur­ing site

7 hours ago
AI
Manufacturing
see latest stream
People

Novo­cure to lay off 200 work­ers, nar­row pipeline for elec­tric fields can­cer ther­a­py

Yesterday

For­mer Terns CEO Senthil Sun­daram pass­es away fol­low­ing bat­tle with can­cer

Yesterday

Ex­clu­sive: Ae­glea re­brands to Spyre, names new CEO in IBD race against TL1A drugs at Mer­ck, Roche and Sanofi

2 days ago
Financing

Ear­ly-stage health­care star­tups are fac­ing a fund­ing cliff

Yesterday

Eu­ro­pean AI start­up rais­es $24M for pro­tein de­sign soft­ware ser­vice

Yesterday

Arv­inas gets $350M boost from in­vestors to ex­tend run­way in­to 2027

2 days ago
Startups

Flag­ship launch­es first UK-based start­up to un­cov­er genes that make cells vul­ner­a­ble or re­sis­tant to dis­ease

Last week

Obe­si­ty and di­a­betes biotech Car­mot Ther­a­peu­tics files for IPO

Last week

Biotech’s IPO out­look for the rest of the year sours in wake of war, broad­er in­dus­try strug­gles

Last week
Deals

Il­lu­mi­na CFO says there's out­side in­ter­est in Grail as 'outright sale' ex­plored

22 hours ago

Bris­tol My­ers bets $100M on Avid­i­ty's RNA ther­a­pies for car­dio­vas­cu­lar dis­eases

Yesterday

So­sei Hep­tares to take back GPCR ag­o­nist af­ter GSK changes course

2 days ago

All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs.

SIGN UP NOW
Subscribe to Endpoints News

In FocusSee all

Ful­ly syn­thet­ic genome nears com­ple­tion in a step to­ward un­rav­el­ing ge­net­ic mys­ter­ies

3 weeks ago
R&D
Discovery

mR­NA’s next trick? Re­pro­gram­ming off-the-shelf cell ther­a­pies for can­cer and au­toim­mune dis­eases

4 weeks ago
Cell/Gene Tx

Ra­dio­phar­ma CD­MOs nav­i­gate sup­ply chain, raw ma­te­r­i­al chal­lenges as de­mand goes nu­clear

4 weeks ago
Manufacturing

Af­ter the ap­plause: New ef­fi­ca­cy ex­pec­ta­tions in urothe­lial can­cer af­ter Pad­cev-Keytru­da da­ta re­veal

4 weeks ago
R&D
Pharma

Endpoints Standouts

A con­ver­sa­tion with No­bel Prize win­ner Katal­in Karikó on re­jec­tion, fi­nal­ly be­ing rec­og­nized and her mR­NA work

Last month
People

Af­ter years of hype, the first AI-de­signed drugs fall short in the clin­ic

Last month
AI
In Focus

How No­vo Nordisk’s Ry­bel­sus went from pan­dem­ic washout to block­buster, and what’s next for oral weight loss

Last month
Pharma
Marketing

Most de­tailed hu­man brain map yet is ‘lay­ing the foun­da­tion for find­ing fu­ture cures’

Last month
R&D
In Focus

Peer review See all

Nov
17

De­sign Ther­a­peu­tics hints at ‘strate­gic re­align­ment,’ re­places CEO; Karyopharm co-founder leads AT­P's Nereid

Nov
10

Cen­tu­ry Ther­a­peu­tics nabs Bris­tol My­ers alum as CEO; En­her­tu star Dai­ichi Sankyo makes changes in Eu­rope

Nov
3

CNS biotech Rap­port snags a CFO vet­er­an from Karuna; Bris­tol My­ers’ new CEO to chair the board next year

Oct
27

Flag­ship's Mon­tai Health hires first CMO; Fi­nance leader to re­tire at J&J part­ner Xen­cor

Oct
20

Co-found­ed by David Bak­er, Vilya rings in a per­ma­nent CEO; Al­lo­gene names Er­ic Schmidt's CFO suc­ces­sor

Pharma channel feed

22 hours ago

FDA opens re­view of CAR-T safe­ty af­ter iden­ti­fy­ing 19 cas­es of post-treat­ment blood can­cer

The FDA is re­view­ing the safe­ty of CAR-T ther­a­pies af­ter re­ports of pa­tients who de­vel­oped blood can­cers fol­low­ing treat­ment with the prod­ucts, an in­quiry that’s al­most cer­tain to raise ...

READ MORE

Bio­Marin lands three-year deal for Ger­man cov­er­age of gene ther­a­py at $900K per pa­tient

23 hours ago
Cell/Gene Tx

No­var­tis ex­ecs high­light progress of slim­mer pipeline af­ter San­doz spin­off

Yesterday
R&D
latest in Pharma

Mer­ck stokes pneu­mo­coc­cal ri­val­ry with Pfiz­er, re­veal­ing up­dat­ed 21-va­lent vac­cine da­ta

Yesterday
R&D

Spring­Works Ther­a­peu­tics ready to launch new­ly-ap­proved desmoid tu­mor treat­ment af­ter three-month de­lay

Yesterday
FDA+

Lo­cal Vir­ginia gov­ern­ments add to in­sulin law­suits against Eli Lil­ly, No­vo Nordisk, Sanofi, oth­ers

Yesterday
Law

US gov­ern­ment turns to more do­mes­tic phar­ma man­u­fac­tur­ing to im­prove sup­ply chain re­silience 

Yesterday
Manufacturing

Sanofi, Re­gen­eron say Dupix­ent suc­ceeds in an­oth­er late-stage COPD study, set­ting up fil­ing for FDA ap­proval

2 days ago
R&D
see latest stories

Marketing channel feed

Yesterday

Mar­ket­ingRx roundup: Pfiz­er adds hol­i­day twist to Covid boost­er ef­fort; No­vavax signs up for sports

Pfiz­er’s lat­est two-at-once vac­ci­na­tion mes­sag­ing taps in­to a hol­i­day theme. A TV com­mer­cial and Tik­Tok ad both cel­e­brate “pie sea­son” with the mes­sage that even if you’ve al­ready ...

READ MORE

Take­da aligns with lead­ing rare dis­ease group for calls to ac­tion around health eq­ui­ty di­ag­noses

Yesterday
Pharma

Who cares about phar­ma ESG ef­forts? Pa­tients and pa­tient groups do — and they want more, sur­vey finds

Yesterday
Pharma
latest in Marketing

Mar­ius aims to shake up typ­i­cal think­ing about testos­terone in new cam­paign

Yesterday
Pharma

Sh­iono­gi brings gen­er­a­tive AI to med­ical con­fer­ences with 'War­rior' por­trait cam­paign

Yesterday
AI
Pharma

Why did Lil­ly give tirzepatide a new name for obe­si­ty? Hint: It’s the mar­ket­ing

Last week
Pharma

Mar­ket­ingRx roundup: Pfiz­er boosts RSV vac­cine Abrys­vo cam­paign; J&J videos spot­light re­named Janssen unit

Last week
Pharma

Phar­ma com­pa­nies qui­et about ad plans on X amid de­par­ture of ma­jor con­sumer brands

Last week
Pharma
see latest stories

FDA+ channel feed

Yesterday

Aldeyra's dry eye drug gets a re­jec­tion from the FDA

The FDA hand­ed down a com­plete re­sponse let­ter to Aldeyra Ther­a­peu­tics for its dry eye dis­ease drug re­prox­alap, fol­low­ing months of spec­u­la­tion about whether the drug would be ap­proved.

READ MORE

Marks: FDA open to us­ing sin­gle-arm stud­ies for ac­cel­er­at­ed ap­proval of rare dis­ease gene ther­a­pies

Yesterday
Cell/Gene Tx

FDA to SCO­TUS: Set­ting the mifepri­s­tone reg­u­la­tions clock back to 2016 is 'un­jus­ti­fied'

2 days ago
Law
latest in FDA+

FDA warns Genen­tech clin­i­cal in­ves­ti­ga­tor work­ing on pre­ven­tive flu an­tivi­ral tri­al

6 days ago

FDA warns Cipla's al­buterol in­haler plant af­ter thou­sands of com­plaints

Last week
R&D
Manufacturing

Im­prop­er Or­ange Book list­ings harm com­pe­ti­tion, FTC says in am­i­cus brief to an­titrust suit

Last week
Pharma
Law

Bernie Sanders in­vites CEOs of J&J, Mer­ck, Bris­tol My­ers to tes­ti­fy on drug pric­ing

Last week
People
Pharma

As­cendis Phar­ma's hy­poparathy­roidism drug scores Eu­ro­pean ap­proval af­ter re­fil­ing in the US

Last week
Pharma
see latest stories

Manufacturing channel feed

11 hours ago

Big Phar­ma unites to help boost re­new­able en­er­gy for sup­ply chains in Chi­na and In­dia

The Sus­tain­able Mar­kets Ini­tia­tive (SMI) Health Sys­tems Task Force — a col­lec­tive of bio­phar­ma and glob­al health com­pa­nies — an­nounced Wednes­day that it is in “ad­vanced dis­cus­sions” ...

READ MORE

RoslinCT to com­mer­cial­ly man­u­fac­ture CRISPR-edit­ed ther­a­py Cas­gevy af­ter col­lab ex­ten­sion with Ver­tex, CRISPR

Yesterday

No­vo Nordisk in­vests $2.4B in French fa­cil­i­ty to ad­dress boom­ing GLP-1 de­mand

2 days ago
latest in Manufacturing

Re­ci­pharm to change CEOs, spin out in­haler busi­ness

6 days ago

GSK boosts low-car­bon in­haler de­vel­op­ment with PhI­II tri­als, in­vest­ment in French man­u­fac­tur­ing fa­cil­i­ty 

Last week
Pharma

Bay­er re­calls one lot of sol­id tu­mor drug Vi­t­rakvi af­ter find­ing mi­cro­bial con­t­a­m­i­na­tion

Last week
Pharma

CD­MOs in­ves­ti­gate how to sup­port GLP-1 man­u­fac­tur­ing, phar­ma con­sid­ers sup­ply chain di­ver­si­ty: #Jef­feries23

Last week

Lil­ly in­vests $2.5B in new Ger­man site to boost tirzepatide sup­ply, $100M for lo­cal biotechs

Last week
R&D
see latest stories
A service from the Financial Times